Civic AI
Procurement intelligence
Federal contract award
TO TITLE: A NOVEL MRNA VACCINE TO PREVENT TRIPLE NEGATIVE BREAST CANCER IDIQ TITLE: PREVENT CANCER PRECLINICAL DRUG DEVELOPMENT PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE ENDPOINT BIOMARKERS
UNIVERSITY OF OKLAHOMA · Department of Health and Human Services
- Value
- $764,880
- Start
- Jun 17, 2024
- End
- Jun 16, 2026
- Action date
- Apr 9, 2026
- PIID
- 75N91024F00002
- Status
- completed
- NAICS
- 541714 · RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)
- Place of performance
- OKLAHOMA CITY, OK
- Award type
- DELIVERY ORDER
Description
TO TITLE: A NOVEL MRNA VACCINE TO PREVENT TRIPLE NEGATIVE BREAST CANCER IDIQ TITLE: PREVENT CANCER PRECLINICAL DRUG DEVELOPMENT PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE ENDPOINT BIOMARKERS
Need modifications, related awards, and vendor peers? Open the full award workspace.